Tezcan, T. Et Al. 2024. Correlation Between MIR-29a-3p Expressıon Level and Dose Normalized Desmethyldiazepam Level in Individuals Diagnosed with Alcohol Withdrawal Syndrome. 14th International Symposium on Pharmaceutical Sciences (ISOPS) 2024 , (Ankara, Turkey), 194.

Tezcan, T., Kotiloğlu, S. Ö., Akyüzlü, D., Yıldırım, M. A., Danışman, M., Bozmaoğlu, C. H., ... Tok, K. C.(2024). Correlation Between MIR-29a-3p Expressıon Level and Dose Normalized Desmethyldiazepam Level in Individuals Diagnosed with Alcohol Withdrawal Syndrome . 14th International Symposium on Pharmaceutical Sciences (ISOPS) 2024 (pp.194). Ankara, Turkey

Tezcan, Tuğba Et Al. "Correlation Between MIR-29a-3p Expressıon Level and Dose Normalized Desmethyldiazepam Level in Individuals Diagnosed with Alcohol Withdrawal Syndrome," 14th International Symposium on Pharmaceutical Sciences (ISOPS) 2024, Ankara, Turkey, 2024

Tezcan, Tuğba Et Al. "Correlation Between MIR-29a-3p Expressıon Level and Dose Normalized Desmethyldiazepam Level in Individuals Diagnosed with Alcohol Withdrawal Syndrome." 14th International Symposium on Pharmaceutical Sciences (ISOPS) 2024 , Ankara, Turkey, pp.194, 2024

Tezcan, T. Et Al. (2024) . "Correlation Between MIR-29a-3p Expressıon Level and Dose Normalized Desmethyldiazepam Level in Individuals Diagnosed with Alcohol Withdrawal Syndrome." 14th International Symposium on Pharmaceutical Sciences (ISOPS) 2024 , Ankara, Turkey, p.194.

@conferencepaper{conferencepaper, author={Tuğba Tezcan Et Al. }, title={Correlation Between MIR-29a-3p Expressıon Level and Dose Normalized Desmethyldiazepam Level in Individuals Diagnosed with Alcohol Withdrawal Syndrome}, congress name={14th International Symposium on Pharmaceutical Sciences (ISOPS) 2024}, city={Ankara}, country={Turkey}, year={2024}, pages={194} }